Zomedica Corp. Financial Ratios
ZOMDF|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-70.9%
Profit Margin
-255.6%
Net Income / Revenue
Asset Turnover
0.25
Revenue / Total Assets
Equity Multiplier
1.10
Total Assets / Equity
Composite: -70.9% (reported: -70.9%)
Profitability
Liquidity
Current Ratio
6.78
Quick Ratio
6.19
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.25
Inventory Turnover
1.87
Days Sales Outstanding
34 days
As of FY2025 · SEC 10-K · Updated Jun 29, 2026
Earnings Quality
Accrual Ratio
-38.4%
-27.1pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.